Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Akebia Therapeutics Inc (NASDAQ: AKBA) closed at $2.43 in the last session, down -4.71% from day before closing price of $2.55. In other words, the price has decreased by -$4.71 from its previous closing price. On the day, 7.03 million shares were traded.
Ratios:
We take a closer look at AKBA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.23. In the meantime, Its Debt-to-Equity ratio is 8.39 whereas as Long-Term Debt/Eq ratio is at 7.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on April 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $7.
On April 01, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Butler John P. sold 46,409 shares for $1.83 per share. The transaction valued at 84,928 led to the insider holds 2,557,921 shares of the business.
Burke Steven Keith sold 7,144 shares of AKBA for $13,074 on Mar 03 ’25. The SVP, Chief Medical Officer now owns 809,090 shares after completing the transaction at $1.83 per share. On Mar 03 ’25, another insider, Burke Steven Keith, who serves as the Officer of the company, bought 7,144 shares for $1.83 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.44 while its Price-to-Book (P/B) ratio in mrq is 25.86.
Stock Price History:
Over the past 52 weeks, AKBA has reached a high of $2.90, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 16.88%, while the 200-Day Moving Average is calculated to be 35.04%.
Shares Statistics:
A total of 261.64M shares are outstanding, with a floating share count of 251.86M. Insiders hold about 4.10% of the company’s shares, while institutions hold 26.42% stake in the company.
